GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Compound class:
Synthetic organic
Comment: WQ-3810 is a fluoroquinolone antibacterial compound, with broad-spectrum activity against Gram-negative and Gram-positive bacteria and against mycobacteria [1-4].
|
|
|||||||||||||||||||||||||||||||||||
| References |
|
1. Itoh K, Kuramoto Y, Amano H, Kazamori D, Yazaki A. (2015)
Discovery of WQ-3810: Design, synthesis, and evaluation of 7-(3-alkylaminoazetidin-1-yl)fluoro-quinolones as orally active antibacterial agents. Eur J Med Chem, 103: 354-60. [PMID:26363871] |
|
2. Kazamori D, Aoi H, Sugimoto K, Ueshima T, Amano H, Itoh K, Kuramoto Y, Yazaki A. (2014)
In vitro activity of WQ-3810, a novel fluoroquinolone, against multidrug-resistant and fluoroquinolone-resistant pathogens. Int J Antimicrob Agents, 44 (5): 443-9. [PMID:25239276] |
|
3. Ouchi Y, Mukai T, Koide K, Yamaguchi T, Park JH, Kim H, Yokoyama K, Tamaru A, Gordon SV, Nakajima C et al.. (2020)
WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis. Tuberculosis (Edinb), 120: 101891. [PMID:31778929] |
|
4. Park JH, Yamaguchi T, Ouchi Y, Koide K, Mori S, Kim H, Mukai T, Nakajima C, Suzuki Y. (2020)
WQ-3810 inhibits DNA gyrase activity in ofloxacin-resistant Mycobacterium leprae. J Infect Chemother, 26 (4): 335-342. [PMID:31839561] |
|
5. Prasad NK, Seiple IB, Cirz RT, Rosenberg OS. (2022)
Leaks in the Pipeline: a Failure Analysis of Gram-Negative Antibiotic Development from 2010 to 2020. Antimicrob Agents Chemother, 66 (5): e0005422. [PMID:35471042] |